Clinical study on the effect of milk-derived peptide on the cognitive function in the elderly volunteers.

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000027064
• Lead Sponsor: Center for Pharma-Food Research, Graduate School of Pharmaceutical Sciences, University of Shizuoka

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-19
• Study Completion: 2018-04-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

Not provided

Exclusion Criteria

1) The subjects who are likely to have allergy symptoms due to test ingredients (milk). 2) The subjects who were diagnosed as patients with dementia 3) The subjects who received surgical operation for stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion injury Head trauma Those with the inpatient surgery. 4) The subjects with medical history of epilepsy or diabetes and/or receiving medical treatment presently. 5) The subjects who is taking medicines (antipsychotic drugs, anxiolytics, antidepressants, antiparkinsonian drugs, antidepressants, antiepileptic drugs etc.) that have a possibility affecting on the cognitive function. 6) The subjects who are participating or planning to participate in other clinical trials at the start of this study. 7) The subjects who are judged as being inappropriate by the responsible doctor.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcomes is Rey-Osterrieth Complex Figure Test (ROCF) at pre and post (for 24 weeks) administration of the repeated intake of milk-derived peptide.

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is the tests below. MMSE Symbol Digit Modalities Test Verbal Fluency Test SF-8 Questionnaire physical examination hematology test urinalysis test